| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8224253 | International Journal of Radiation Oncology*Biology*Physics | 2012 | 6 Pages |
Abstract
For IBC patients, the rate of distant metastases is still high despite excellent local control, particularly for patients who received >60.4 Gy to the chest wall. Despite the use of taxanes and trastuzumab, outcomes remain modest, particularly for those with ER/PR-negative disease and those without a pathologic complete response.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Sana B.S., Chandana A. M.S., Rahul D. M.D.,